Cordyceps Sunshine Biotech Holdings Income Statement (2020-2025) | RAJAF

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2020 Dec2021 Dec2022 Sep2023 Dec2023 Dec2024 Dec2025
Revenue & cost
Revenue (Quarter) 0.32M
Cost of Revenue (Quarter) 0.03M
Gross Profit (Quarter) 0.28M
Operating items
Restructuring Costs (Quarter) 0.08M0.35M
Other Operating Expenses (Quarter) -0.00M-0.19M
Operating Expenses (Quarter) 0.08M0.16M
Operating Income (Quarter) -0.04M0.12M
EBIT (Quarter) -0.04M0.12M
Non-operating items
Non Operating Income (Quarter) -0.01M-0.08M0.00M
Net income details
EBT (Quarter) -0.04M0.08M
Profit After Tax (Quarter) -0.08M0.06M
Income from Continuing Operations (Quarter) -0.04M0.08M
Consolidated Net Income (Quarter) -0.37M-0.30M
Income towards Parent Company (Quarter) -0.37M-0.30M
Net Income towards Common Stockholders (Quarter) -0.37M-0.30M
Additional items
EPS (Basic) (Quarter) -3.720.000.01
EPS (Weighted Average and Diluted) (Quarter) -3.720.000.01
Shares Outstanding (Weighted Average) (Quarter) 100.00M0.10M104.42M111.12M111.12M111.12M111.12M
Shares Outstanding (Diluted Average) (Quarter) 100.00M0.10M104.42M111.12M111.12M111.12M
EBITDA (Quarter) -1.29M0.67M